Ann Garnier, Co-Founder and CEO of Lisa Health, is a seasoned healthcare leader and operator, helping to create, launch, and scale innovative healthcare technology companies and products that have improved patient outcomes and access to care. Prior to Lisa Health, Ann was COO at CarePayment, Senior Vice President at RelayHealth, Vice President at Paradigm Health, and fractional senior executive and advisor to numerous venture-backed companies. She is passionate about using technology to transform women’s health, advancing research on menopause and healthy aging, and helping women thrive in midlife. Ann is the co-creator of Lisa Health’s Midday app for menopause and healthy aging.

Shelly Lanning is the Co-Founder and President of Visana Health, a virtual-first comprehensive women’s health clinic. Shelly has been a healthcare investor for over 20 years, with a focus on early and commercial-stage medical technology, healthcare services, and health and wellness companies. She has served on more than a dozen company Boards and chaired audit, compensation, and clinical committees.

Shelly holds an MBA from the University of Pennsylvania’s Wharton School of Business and a BA from the University of Minnesota. She is a Kauffman Fellow, Class VI.

Dr. Amy Divaraniya is the Founder and CEO of Oova, a women’s health company. She has more than 10 years of experience as a data scientist and has both led and published original research in the areas of personal genomics and biomarker discovery. Her solid understanding of biology and being able to apply complex analyses have led to innovative projects in the healthcare space. In 2017, Dr. Divaraniya chose to pivot her career as a data scientist and devote herself to improving women’s healthcare. After facing her own struggles with conceiving her son, Dr. Divaraniya decided to build a solution to help women experiencing difficulty getting pregnant. Today, she and her team have built the first at-home test, Oova, that measures multiple hormones through urine samples and provides personalized results and insights on a woman’s fertility. Oova has resonated with many women and clinicians and has now been adopted by over 100 clinics and hospitals across the country.

Dawn Laguens is the Chief of Global Strategy and Innovation at Planned Parenthood Federation of America where she guides strategy, innovation, insights, digital products and Planned Parenthood Global. She previously served as Planned Parenthood’s Executive Vice President and Chief Brand Officer. Dawn is a frequent media spokesperson and presenter at top global conferences —including Ad Week, Aspen Spotlight Health, the Fortune Tech Summit, SXSW, Rock Health, Girlboss and TEDx. She was recently named #5 on Fast Company’s fourth annual Queer 50 list. Dawn is a champion of emerging technology, and personally led the production of Across the Line, an award-winning virtual reality experience that debuted at the Sundance Film Festival and was among the first VR films used in the social impact and education space.

For two years Dawn was Expert In Residence at IDEO, the world leading human centered design firm, where she worked alongside global designers, creators and problem solvers to imagine and prototype the socially responsible and responsive organizations, corporations and technology needed for a healthier and happier future for both people and the planet. Dawn loves tennis, the printed word and her dogs, and is the mother of triplets with her wife Jennifer. They live in Austin, Texas.

Emanuela Kufel is an entrepreneur and an advocate for universal mental health care. After years of working for the NHS and NIHR, she started her own company, Prosoma, supporting the mental and behavioral health of cancer patients. Her interests lie in fem tech, med tech, and digital therapeutics.

Kimball Wilkins has 20+ years of healthcare experience and is currently Vice President, Digital Experience at Blue Shield of CA, where she formerly led Brand, Market Strategy, and Insights.

With a strong track record of delivering business results, building talented teams, establishing firsts and designing for the customer, she is effective at inspiring others and collaborating to drive the right kind of change. A former producer of theater, Kimball holds a Ph.D. in English from U.C. Berkeley. She has studied, taught and worked with many different organizations in the public and private sectors.

Key Accomplishments: Digital Channel Management & Customer Experience: Led significant increases in self-service, user satisfaction, channel containment and other key metrics over 48-month period. Oversaw operational and strategic investments and execution across enterprise commercial platforms, including consumer, employer, broker and provider. Launched enterprise Net Promoter Score incentive program and drove digital experience improvements leading to improved competitive Forrester ranking. Established new leadership bench to enable enterprise digital transformation. Brand: Repositioned a leading health insurer three times over a twelve-year period and created the company’s brand values. As a result, delivered increased differentiation, market share and performance on reputation. Contributed to 10% increase in employee pride within first 18 months of latest refresh. Growth Strategy: Delivered blueprint for

growth leading to significant investments in key segments and entry into new markets/channels, supporting 20% membership and 30% revenue growth within 36 months. Team: Strong track record of attracting & retaining top talent at all levels. Sought-after mentor and thought partner to employees pursuing professional growth.

Preceding her career in healthcare, Kimball co-founded a widely reviewed, award- winning theater company known for its daring vision and bold aesthetic choices, serving as Executive Producer for seven years. She taught literature & writing courses for 5+ years in U.C. Berkeley’s English Dept. (consistently ranked #1/#2 nationally in U.S. News & World report), where she won multiple teaching and research awards.

Mary Jacobson, fondly known as Dr. J, is Alpha’s Chief Medical Officer. Dr. J received her medical degree from Georgetown University School of Medicine. She is an accomplished academic, board-certified obstetrician and gynecologist with extensive experience in clinical care, medical education, hospital operations, and research. She completed her residency and fellowship at the Stanford University School of Medicine. In her free time, she enjoys stargazing, yoga, and baking bread. Dr. J is committed to making Alpha our patients’ online primary care provider by increasing access to care through an asynchronous telemedicine platform. She is licensed in all states where Alpha treats patients.

Dr. Fahimeh Sasan is Chief Innovation Officer at Kindbody where she builds and leads programs that help employers deliver equitable and inclusive reproductive care and family-building benefits programs to their global workforces. Kindbody is a leading fertility clinic network and global family-building benefits provider for employers offering the full-spectrum of reproductive care from preconception to postpartum through menopause. 

Dr. Sasan is a board certified Ob/Gyn who completed her residency in obstetrics and gynecology at Mount Sinai Hospital in New York City, which was named to Newsweek’s list of “America’s Best Maternity Hospitals 2022”. In addition to her work at Kindbody, Dr. Sasan is an Assistant Professor of Obstetrics, Gynecology, and Reproductive Medicine at Mount Sinai Hospital in New York. As a practicing clinician for more than 15 years she is dedicated to helping her patients with comprehensive care with a focus on providing an exceptional, personalized experience. At Kindbody, Dr. Sasan and her team provide fertility services, gynecology, low-risk and high-risk prenatal care, and wellness support, offering patients a single door for all of their reproductive care needs. 

Dr. Sasan is deeply committed to promoting healthcare literacy as a form of preventative healthcare, empowering people with the essential knowledge to take control of their health. She is a frequent speaker on reproductive health and education, maternal care, and the impact social determinants of health have on people’s health, well-being, and quality of life. She was instrumental in Kindbody’s partnership with Walmart, which provided reproductive and fertility care and surrogacy to Walmart’s entire U.S. workforce for the first time.

Alessandra Henderson is the Co-Founder & CEO of Elektra Health, a next-gen women’s healthcare platform on a mission to smash the menopause taboo. Elektra’s end-to-end, virtual care platform empowers women with evidence-based education, care & community. Elektra partners with leading health plans including Mass General Brigham Health Plan and EmblemHealth to close the post-reproductive women’s healthcare gap. Prior to Elektra, Alessandra spent 10+ years building early stage consumer businesses at Artsy, the MIT NYC Startup Studio, and Human Ventures. She holds a B.A. from Vanderbilt University and MBA from MIT Sloan, where she received the Martin Trust Award and Patrick McGovern Entrepreneurship Award. Her work has been covered by The NY Times, Fast Company, Techcrunch, Fortune and more.

Heather Bowerman is the Founder and CEO of DotLab, a molecular diagnostics company in women’s health and the creator of the DotEndo™ test for endometriosis. Bowerman has been recognized as a TR-35 Global Innovator by the MIT Technology Review, a World Technology Award Finalist for Health & Medicine, and as one of the 100 Most Intriguing Entrepreneurs by Goldman Sachs. She was previously a management consultant at McKinsey & Company in healthcare and technology, Harvard’s nanotechnology teaching fellow, and an associate in the Obama White House’s Office of Science & Technology Policy. She is a graduate of the UC Berkeley College of Engineering and Harvard University. DotLab has been named as an “Amazing Medical Breakthrough” by Reader’s Digest and as one of the “Fierce 15” companies by FierceMedTech.

Jessica Karr is the Founder & General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica’s experience launching novel impact-focused products began when she joined Impossible Foods as the 12th employee, where she helped develop and launch the Impossible burger. She has since worked with startups internationally as an innovation consultant and as a Principal with a family office. She is an LP in women-led funds and her angel investments have all become unicorns. Jessica holds a MS in Biochemistry from UC San Diego, an MBA from Presidio Graduate School, and a BA in Philosophy from Texas State University. Jessica lives in the Bay Area with her rescue Pom and enjoys swimming in the bay.

Named one of Inc. Magazines Top 100 Female Founders of 2020, Courtion is a distinguished and award-winning consumer marketer, inventor (21 issued patents), and femtech leader who is revolutionizing the $600 billion dollar menopause market with Joylux—the leader in at-home medical devices, personal care products and digital tools for menopausal women experiencing vaginal and sexual health issues. With over 20 years of cross-functional expertise leading consumer product, retail, and medical device companies, she is known as a category creator in

the emerging health and wellness space. Prior to founding Joylux and her other two skincare related start-ups, she was a marketing executive with Starbucks responsible for launching and growing the Starbucks Card and Customer loyalty program into a multi-billion-dollar business. Courtion and her companies have earned numerous accolades including the AARP Innovation Lab’s Women’s Health Award (2021), Angel Capital Association’s Most Innovative Company (2019), Best Product of the Year (2003) for Starbucks Duetto Card from Business Week, Top 15 Women of Influence (2009) in Seattle and Top 40 Under 40 leaders (2006) in Seattle from Puget Sound Business Journal.

Megan Dover is Co-founder and Principal of Cross Border Impact Ventures (CBIV).  At CBIV, she invests in Series A stage health technology companies in North America and Europe that address unmet needs for women and children globally.  Key health focus areas for the fund include maternal & newborn health, sexual & reproductive health and chronic conditions that impact women and children such as oncology, cardiovascular health, mental health, gut health and respiratory health. 

She has in depth experience in venture capital, impact investing, venture advisory, M&A, business strategy, Financial Planning & Analysis and angel investing. Prior to the launch of CBIV, Megan was the Senior Investment Manager for the Every Woman Every Child Innovation Marketplace at Grand Challenges Canada, and acted as a venture advisor to support the fundraising efforts of a portfolio of early stage health technology companies in raising equity and grant capital. Megan brought expertise in a number of areas to the role, having previously held roles in finance and strategy for a multinational public company, worked in management consulting for a global consulting firm, been part of an R&D team for a biotech startup and as an advisor and angel investor at the Creative Destruction Lab (CDL). Megan obtained her MBA from the Rotman School of Management at the University of Toronto, receiving a Dean’s list ranking. She also earned her Engineering degree with Honours from Queen’s University, specializing in Biomedical Research within Chemical Engineering.

Megan is passionate about supporting world class technology companies that are scaling tech for good. She is also a big fan of women in STEM, women in business, women’s health, women leaders and more women supporting women.

Kate Steinle, MSN, WHNP is the Chief Clinical Officer at FOLX Health, which is a health and wellness platform providing telehealth services to the LGBTQAI+ community. The model of care at FOLX is focused on creating joyful, affirming healthcare on one’s own terms and building community and access around those needs. 

Prior to joining FOLX, Kate was providing in-person sexual and reproductive healthcare in NYC for over a decade. Kate has led the implementation of many clinical services, and believes healthcare can be a place of radical transformation and empowerment, for both those who access care and for the providers of the care. Kate’s clinical practice is based on listening with intent and responding with kindness, clarity, and authenticity.

As CMO, Dr. Genen oversees medical management and quality operations at ProgenyHealth. As an experienced physician executive who has focused on maternal child health, Dr. Genen led as a Senior Research Fellow for UnitedHealth Group Research and Development prior to joining ProgenyHealth, helping to advance research and develop innovations in healthcare. Prior to moving to R&D, she served as the Chief Medical Officer for Women’s Health at Optum overseeing Fertility, Maternity and NICU programs.

Mandy (she/her) is on a mission to change how America handles the fourth trimester. After learning first-hand how little we support and inform new parents during postpartum, she left her 10-year+ career in digital media to dedicate herself to birth work and closing the gap in postpartum care. Today, she is a certified postpartum doula and the founder and CEO of Major Care™. Mandy is also the postpartum content advisor for BabyCenter’s medical advisory board, a postpartum instructor at Motherly, and an active member of PSI. Mandy holds a MA from Columbia Journalism School and has been a contributing perinatal expert for HuffPost, Healthline.com and more, writing on postpartum best practices and addressing postpartum inequities.

“Until women’s health is health — full stop — dedicated spaces and conversations like this summit are essential to propelling innovation, funding and partnerships forward in order to improve care delivery, address care inequities, and better outcomes for women and birthing bodies across the spectrum of our lived experiences.”

Joanna is the founder of Midi Health, a virtual care platform for women in perimenopause and menopause. The company brings expert care, covered by insurance, to women nationwide. Prior to Midi, Joanna founded Kurbo, the first digital therapeutic for childhood obesity, which was scaled to help tens of thousands children worldwide and the company was successfully sold to Weight Watchers in 2018. Prior to diving into digital health, Joanna spent more than 20 years in direct private equity and venture capital investing in health and consumer companies including a number of notable consumer internet companies, including BlueNile, eToys, Babycenter, HotJobs and Flycast.

Joanna is the author of the book Getting to 50/50, a primer on how women can succeed and thrive at work and at home. She has spoken extensively to corporate and graduate school audiences on the topic of women and leadership. She was also named to the Forbes 50 over 50 list of top Innovators in 2023.

Tiffany Inglis, MD, is the National Medical Director at Carelon focused on Women’s and Children’s Health. She has developed, launched, and scaled programs with predictive analytics, digital member engagements, and partnerships with providers supported by clinical staff focused on value-based solutions that transform healthcare for women, children, and families. Before she was in her current role, she was the Director of Medical Operations at Elevance Health in the Commercial Ohio market and then the Clinical Medical Director for Population Health.

Laura Keyser, DPT, MPH is a clinician-leader and public health professional with expertise in women’s and pelvic health and over 15 years of experience. She is a skilled researcher, writer, speaker, and educator with demonstrated professional competence in several key areas including maternal/women’s health, life course health development/health disparities, public/population health, digital health, capacity building and health care delivery models, with a focus on low resource and conflict settings. In the U.S. Dr. Keyser has worked with a women’s health company focused on digital health innovations for female pelvic floor disorders, contributing to product development and research efforts, including efficacy trials, real-world evidence generation, health economics work, and clinical decision-making tools. Her international experience includes women’s health and physiotherapy capacity building in India and multiple countries across Africa, with a focus on special populations, such as women with obstetric fistula, survivors of sexual violence, and pregnant/postpartum individuals. Dr. Keyser has published and lectured on her work in global and women’s health and consulted with local and international organizations, including EngenderHealth, USAID, Johnson & Johnson, Panzi Hospital & Foundation, and Global Strategies. She serves as an assistant clinical professor at the University of California, San Francisco, as co-founder of Mama LLC, and most recently as a founding member of Axena Health, Inc.

Dr. Jin Lee is a digital health investor and entrepreneur. She has worked in the venture and innovation arms of pharma, payer, and provider space- responsible for product and commercialization.. Based in Silicon Valley, Dr. Lee advises and invests in digital health startups and accelerator programs. She also serves on multiple nonprofit boards, including the American Heart Association and the Healthcare Businesswomen’s Association.

Avestria Co-Founder Linda Greub has been investing in public and private life science companies for over 30 years. At Avestria, Linda invests in early-stage women’s health companies and female-founded life science ventures. Previously, Linda co-founded LMN Ventures, one of the first investors in nVision Medical which was acquired by Boston Scientific in 2018 for up to $275 million. Additional exits included KeVita and Yasso. 

Linda’s corporate experience includes leading M&A at both Novartis Diagnostics & Applied Biosystems where her transactions included the $5.1 billion cash and stock sale of ABI to Life Technologies (acquired by Thermo Fisher) in 2008. She has held corporate development and finance roles at a number of venture-backed life science companies, including VitaPath Genetics, Singulex, Raindance Technologies (acquired by Bio-Rad) and Linkage Biosciences (acquired by Thermo Fisher). 

As a member of private investment partnerships, including Tudor Investments and Essex Investment Management, she invested over $3.2 billion of equity capital, including $1.1 billion of performance-based hedge funds. She also built profitable equity research franchises in healthcare services at both Banc of America Securities and Pacific Growth Equities, successfully raising over $1.8 billion of capital for public companies.

Linda earned her BA in the History of Art from Yale and her MBA from Harvard. She is a Chartered Financial Analyst.

As a General Partner at Felicis, Victoria is focused on the reinvention of financial services, infrastructure, security, enterprise, and health tech. She led Felicis investments in Dovetail, SentiLink, Alloy, Maze, Midi, and others.  Victoria’s angel investment and advising track record includes Roadie (acquired by UPS), Faire, Betterment, Galileo Health. Previously, Victoria served as Chief Revenue Officer of Kabbage (acquired by American Express) and CMO at Ring Central. At Kabbage Victoria was responsible for building the company’s revenue and go-to-market teams, resulting in nearly $300 million in revenue after six years of 100%+ annual growth. Victoria’s deep operating experience includes sales, marketing, partnership, and product management functions. Victoria served as CMO of RingCentral and General Manager at Amazon. Victoria holds a double degree with distinction in Business and International Studies from the University of Washington and an MBA from Harvard Business School.

At Avestria Ventures, Tracy brings a unique blend of strategic and operational experience to support portfolio companies, drawing on her digital health and life science innovation experience.  She has advised global Fortune 500 companies, startups, and NGOs, working with organizations like the Novartis Digital Accelerator Lab and the Bill and Melinda Gates Foundation.

Tracy’s corporate experience spans innovation pipeline development, strategy, and operations.  At Novartis Diagnostics (acquired by Grifols), Tracy served on the Deal Review Committee, Operating Committee, and Commercial Council.  She joined Novartis as Chief of Staff to the President, leading strategic planning and early-stage innovation partnerships.  She subsequently served as Head, Global Support & Operations at Novartis and Grifols with responsibilities for portfolio-wide business operations, including lifecycle management and new channel entry for over 15 product launches.  

Tracy began her career as a healthcare mergers & acquisitions investment banker.  She advises entrepreneurs through the TechStars x United Health accelerator, UCSF Health Hub, and serves on the Springboard Women’s Health Executive committee, along with the Research & Evidence subcommittees of the MedTech Color Collaborative Community.  

Tracy holds an MD from Stanford and a BS in Biomedical Engineering from the University of Southern California.

Dr. Kandis Daroski, DPT is Hinge Health’s pelvic health subject matter expert and physical therapy Product Consultant. She advises pelvic health clinical program development including clinical safety guidelines, exercise prescription, and education content creation and review. Her work has helped to define a care delivery model to provide access to digital pelvic health for over 10 million lives. She received her Doctorate in Physical Therapy from West Virginia University in Morgantown, West Virginia in 2016. She has received advanced pelvic health training through the Herman and Wallace Pelvic Rehabilitation Institute and is a pregnancy and postpartum corrective exercise specialist. She enjoys advocating for conservative approaches to treatment,  such as exercise and movement therapy,  as a means of alleviating symptoms and allowing patients to lead more fulfilling lives. She is passionate about providing education on pelvic health conditions as evidenced through her attributions in Yoga Journal, the Bump, Huffington Post, and Popsugar and more.

Lily Huang joined NEA in 2017 and is currently a Partner on the Med Team. Lily is focused on healthcare services and technology companies. She serves on the board of Curana, Elion, and Vori Health and is a board observer for Aetion, Belong Health, Everside Health, Strive Health, and TriValence.

Prior to joining NEA, Lily spent three years as a member of TPG Capital’s North America Buyouts Group, focusing on investments in healthcare. At TPG, Lily worked on private equity transactions across biopharma, healthcare services, and other generalist industries including TPG’s acquisition of Beaver-Visitec and Ellucian Inc. Lily graduated summa cum laude from the University of Pennsylvania with a B.A. in Biology and B.S.E. in Finance.

Anna Valcheva works with venture capital, private equity, startup founders and entrepreneurs on investments and exits at various stages of the private capital cycle – from seed and early-stage to late-stage, and pre-IPO. She is a Venture Advisor for Waterman Ventures, Alumni Ventures Group – the most active U.S. early-stage Venture Capital group, having invested over $1bn into 1000+ companies. Previously, she was a Managing Director at FNEX Capital, a merchant investment bank and investment platform for late-stage direct venture capital. Anna was a founding member of the first private equity sponsor and investment banking advisory firm for women founders and the C-suite of executive women on business and investor side. Anna spent the majority of her career at JPMorgan, in New York, London and Sydney, in Investment Banking M&A, Private Equity, Equity Capital Markets, Equity Derivatives and Equity-linked Capital. She was a co-founder of startup business lines at JPMorgan that were built from the ground up into the #1 leading franchises in their domain in the U.S. and EMEA. She was Investment Advisor for sustainable, impact investments for the United Nations and UNDP organizations around the world, Advisor to the “100 Startups Against Cancer” CAI-MedImmune-AstraZeneca pre-seed healthcare startup accelerator, Advisor to the Tamer Fund for Social Ventures, a pre-seed and early-stage accelerator for impact startups, among others. She is passionate about mission-driven entrepreneurship, double bottom-line impact investing, healthcare, healthcaretech, femtech, digital health, mental health, neuroscience, functional medicine, nutritional sciences, environmental stewardship and women founders. Anna is an alumna of Brown University in the U.S., holding a Bachelor’s Degree in Applied Mathematics-Economics, International Relations, and Organizational Behavior and Management, with Honors, Magna Cum Laude, and of Oxford University in the U.K.. She holds the global MBA of Columbia Business School in the U.S. and London Business School in the U.K..

Alice has been a women’s health enthusiast throughout her career spanning global health, clinical medicine, and the private sector. She is currently a Principal at RH Capital leading investments in innovative women’s health companies across the life sciences, digital health and consumer health. Alice was previously a women’s health practice leader and management consultant at McKinsey & Company, where she served biopharma, diagnostics, global public health and private equity clients across R&D and commercial strategy topics.

Earlier in her career, Alice’s passion to improve lives for the underserved led her to work in East Africa and Asia in reproductive health and family planning. As a clinician, she focused on women’s health globally and published articles examining healthcare in low-income countries.

Alice holds an MBA from Harvard Business School and MD and MPH from the University of Michigan, where she was a Dean’s Merit Scholar. Alice is a frequent speaker on FemTech and women’s health innovation and holds advising and mentoring roles with multiple women’s health accelerators and forums. She has also been a patient in many women’s health areas including infertility, termination, and pregnancy complications. 

Dr Fineberg has 25 years of experience collaborating with midwives in the hospital and community.  Her team was recognized and awarded as a successful model of collaborative practice by ACOG and ACNM. She was part of the working group that created the CMQCC toolkit to support vaginal birth and safely prevent cesarean and recently assisted with their Hospital Action Guide for respectful and equity-centered obstetrical care. She also led a successful campaign to reverse a 10-year VBAC ban at Sutter Davis Hospital. She recently returned to Berkeley to examine the systemic issues affecting maternal experiences and outcomes.

As Vice President of Product Management, Janna is responsible for defining and driving ProgenyHealth’s product strategy with a human-centered approach. Janna brings nearly 20 years of experience in commercializing, implementing, and scaling multi-channel population health and chronic condition management programs. Her work is centered at the intersection of clinical program design, user experience, and technology. At ProgenyHealth, Janna is focused on scaling integrated maternal and infant care management programs to optimize reach, member satisfaction, and health outcomes.

Lindsay Parham, PhD, JD, is the Executive Director for the Wallace Center for Maternal, Child and Adolescent Health, a research and training center at UC Berkeley that conducts actionable research in innovation and technology to advance maternal, child and adolescent health. She is a social scientist and lawyer specializing in women’s health policy and healthcare organizations. With over a decade working in reproductive rights, ethics, justice, and health, Dr. Parham brings unique sociological and legal expertise to challenges in real-world clinical settings. Her work focuses on systems and policy analysis to find and close gaps in care for women throughout the reproductive cycle. She is passionate about using technology and innovative interventions to improve care throughout the reproductive life cycle. Dr. Parham earned her B.A. at Cornell University, and her joint PhD and JD at UC Berkeley School of Law.